Silver Book reference

Cost Effectiveness of Pramipexole in Parkinson’s Disease in the U.S.

1 Matching Fact

Search matching Facts:
No results to display
    • A study of Parkinson’s disease treatments found that pramipexole is a cost-effective treatment for early and advanced Parkinson’s disease. The total cost-effectiveness ratio was $8,837/QALY for patients with early Parkinson’s…